Skip to main content
Main analysis: Diplomat 2025: Sales Still Grew, but 2026 Already Looks Like a Capital Test
ByMarch 27, 2026~10 min read

Diplomat New Zealand: A Concentrated Market, Small Acquisitions, and Profit That Nearly Disappeared

The main article already treated New Zealand as Diplomat’s sharpest warning sign. This follow-up isolates why: local-currency sales still grew, but in a market where a few retailers hold the power, category expansion and small acquisitions left almost no operating profit behind.

The main article already established that New Zealand is the sharpest outlier inside Diplomat: a segment that generated NIS 262.2 million of revenue, yet finished 2025 with only NIS 145 thousand of segment operating profit. This follow-up isolates only that thread. The question here is not whether Diplomat can sell in New Zealand. It can. The question is whether it can create value there, or only volume.

What still works is clear enough. Sales in local currency rose by 7.7% to NZD 131 million, the company broadened its food portfolio, CBL was consolidated for the first time, and Blue Coconut was acquired at the end of November. But the bottleneck became sharper: gross profit fell, margins compressed, discounts increased, and operating costs moved higher. In other words, New Zealand does not look like a demand problem. It looks like a margin trap.

Four points frame the thesis:

  • This is not just an FX translation issue. Excluding roughly NIS 24 million of negative translation, the segment would have shown about NIS 15 million of revenue growth in 2025. Even so, operating profit almost disappeared.
  • Concentration is a mechanism, not just a datapoint. Foodstuffs and Woolworths together control about 80.2% of New Zealand’s FMCG market, and four disclosed customers represented 79% of Diplomat New Zealand’s 2025 sales.
  • Category expansion worked in volume, not in profit. Food revenue rose to NIS 59.0 million in 2025 from NIS 40.0 million in 2024, yet segment gross profit fell to NIS 40.9 million from NIS 46.1 million.
  • The capital is already in before the margin exists. Segment capital investment jumped to NIS 19.3 million from NIS 0.5 million, average inventory days rose to 64 from 60, and the two New Zealand acquisitions cost at least NIS 12.0 million before any contingent consideration on CBL.

This is not just FX noise. It is real pressure in the local economics

The easy read on 2025 is that the New Zealand dollar weakened against the shekel, so the picture looks worse than it really is. That is only partly true. The closing rate of the New Zealand dollar fell by 10.3%, and the average rate fell by 10.4%, so reported revenue in shekels did decline to NIS 262.2 million from NIS 271.6 million. But that is not the core of the story.

The core of the story is that the local business still grew, yet its economics weakened. Sales in local currency rose to NZD 131 million from NZD 121 million. Management also explains that excluding translation, the segment would have shown roughly NIS 15 million of revenue growth, driven mainly by organic growth, new food brands, and the first-time consolidation of CBL. So the New Zealand problem in 2025 is not that sales disappeared. The problem is that more sales no longer produced more profit.

New Zealand: sales held up, margins collapsed

The numbers are stark. Gross profit fell to NIS 40.9 million from NIS 46.1 million, and segment operating profit collapsed to NIS 145 thousand from NIS 8.0 million. Gross margin dropped to 15.6% from 17.0%, and operating margin compressed to 0.1% from 2.9%. This is no longer a case of margins being mildly pressured. It is a segment that almost stopped generating profit.

One nuance does matter, because it softens the headline without changing the conclusion. The company says that 2024 in New Zealand included a one-off income item of about NIS 6 million from a reversal of doubtful-debt provisions. That means the 2024 base was flattered. Even so, stripping that out still leaves a roughly NIS 2 million adjusted 2024 operating profit. 2025 almost erased even that.

Metric20242025Why it matters
Reported revenueNIS 271.6 millionNIS 262.2 millionTranslation into shekels hid part of the local growth
Revenue in local currencyNZD 121 millionNZD 131 millionThe business still grew in volume and categories
Gross profitNIS 46.1 millionNIS 40.9 millionThe erosion moved into the economics, not just the currency line
Segment operating profitNIS 8.0 millionNIS 0.145 millionAlmost no profit remained after discounts and opex
Capital investmentNIS 0.5 millionNIS 19.3 millionMore capital went in just as returns weakened
Average inventory days6064Category expansion tied up more working capital

That table is why New Zealand is more interesting than just another weak line item. It shows a segment where the company still knows how to expand sales, but the mechanism that turns sales into profit has broken.

Four customers control the shelf, and two retailers control the market

On paper, Diplomat New Zealand sells to roughly 850 customers nationwide. In practice, the economic power is far narrower. In 2025, 76% of sales came from national chains, 14% from convenience, and only 10% from the private market. That is already concentrated. One layer down, it looks tighter.

Diplomat New Zealand customer concentration, 2025

Woolworths alone was 29% of segment sales. Foodstuffs North Island was 26%, Foodstuffs South Island another 10%, and Chemist Warehouse 14%. Together, those four customers accounted for 79% of Diplomat New Zealand’s sales. So the real story of New Zealand is not 850 customers. It is four disclosed customers, and two retail groups that dominate the center of gravity of the market.

At the wider market level, the company itself says the New Zealand FMCG sector operates as a duopoly. Foodstuffs holds about 48.8% of the market, Woolworths about 31.4%, and that structure creates a high barrier to entry while giving the two chains substantial negotiating power with suppliers. That is not a side note. It is the definition of the market’s economics.

The implication is that every category expansion still has to pass through the same power centers. Diplomat can add brands, widen its food portfolio, move into more niches, and even benefit from rising retail competition after Costco’s entry and Chemist Warehouse’s expansion. But as long as shelf space, promotions, and order volumes are negotiated with a small set of large retailers, the distributor’s pricing power remains limited.

And that is exactly what 2025 shows. The company does not describe a lost customer or a collapse in demand. It describes sales-mix pressure, higher discounts, and higher operating costs. In other words, the pressure came through trading terms and the economics of selling, not through a crude top-line drop.

Small acquisitions broadened the category, but they did not create value yet

If there is a smart counter-read to this article, it would sound like this: New Zealand is simply in a transition year. The company built a new food layer there, added owned brands, bought one bolt-on in May and another at the end of November, and 2025 is therefore a build year rather than the year by which final profitability should be judged.

That is a serious argument. But it still has to go through the numbers.

Food expansion in New Zealand: more category, less contribution to profit

Food revenue rose to NIS 59.0 million in 2025 from NIS 40.0 million in 2024 and NIS 19.2 million in 2023. At the same time, non-food revenue fell to NIS 203.2 million from NIS 231.6 million. So the segment clearly shifted toward food categories and company-owned brands. That supports the strategic direction. But it also sharpens the problem: category expansion did not stop the economic erosion.

Management explicitly says the revenue growth excluding FX came mainly from new food brands, roughly NIS 7 million, and the first-time consolidation of CBL, another roughly NIS 7 million. In other words, part of the growth came from exactly the places that were supposed to improve the quality of the portfolio. Even so, the same report says operating profit fell because of sales mix, higher discounts, and higher operating costs.

That is where the two 2025 acquisitions come in. On May 1, the company bought 75% of CBL for about NZD 4.265 million, equal to NIS 9.7 million in accounting purchase consideration, with additional contingent consideration of up to about NZD 525 thousand. On November 28, it bought the Blue Coconut activity for about NZD 1.243 million, equal to NIS 2.32 million. Taken together, the two deals cost at least about NIS 12.0 million before any potential contingent payment on CBL.

That is not a large number at the group level, but it is already very large relative to a segment that ended the year with NIS 145 thousand of operating profit. The structure matters too. CBL did not just bring revenue. It also brought NIS 11.7 million of intangible assets and NIS 3.14 million of goodwill. Blue Coconut was bought only at the end of November, so it could not realistically rescue 2025. The practical meaning is that the company has already paid for category expansion, but has not yet shown that the move creates margin.

There is also a less visible operating layer here. In New Zealand, Diplomat does not run logistics itself. Storage, picking, and distribution are performed by Mainfreight under a TPL model, and the company also uses an outside provider for shelf-merchandising services. The Mainfreight agreement runs through May 2028. That matters because in a structure like this, a small bolt-on does not automatically create warehouse synergies or internal operating leverage. First it adds brands, inventory, complexity, and more commercial negotiations with the same customers. If operating leverage comes, it comes later.

The working-capital numbers support exactly that read. The company explains that New Zealand inventory increased by about NIS 5 million because of new brands and the first-time consolidation of CBL. Average inventory days rose to 64 from 60, average customer credit rose to NIS 20.4 million from NIS 15.0 million, and average customer days increased to 26 from 24. Supplier credit did improve to 46 days from 39, which helps. But the overall picture stays clear: the new category consumes capital now, while the margin has not yet proved itself.

What New Zealand has to prove from here

New Zealand is no longer being tested on whether it can add another brand, another category, or another small bolt-on. 2025 already proved that it can. It is being tested on three sharper questions.

The first is whether the new food portfolio can lift gross margin, not just revenue. As long as food and company-owned categories grow while discounts and sales mix keep eroding profitability, the expansion remains a volume move.

The second is whether CBL and Blue Coconut will remain deals that add SKUs and inventory, or whether they will become anchors that strengthen Diplomat’s commercial position. In 2025, it is still too early to say that they already have. CBL added sales, Blue Coconut could barely contribute within the year, and the segment’s total profitability almost disappeared.

The third is whether Diplomat can generate margin in New Zealand even without an internal logistics-synergy engine. That is more important than it first looks, because it tests the company’s ability to create value in a market where bargaining power sits mainly with the retailer, not the distributor.

The bottom line of this follow-up is sharp: New Zealand is not a scale problem. It is an economics problem. The segment is small in revenue terms, but analytically important because it shows the limits of Diplomat’s power in a concentrated market. If the company can restore profitability there while keeping the new categories, that will be real evidence that it can create value even in a market where the shelf is controlled by very few hands. If not, New Zealand will remain a case study in how good brands, small acquisitions, and local growth still do not add up to profit when bargaining power sits with the customer.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction